Featured Research

from universities, journals, and other organizations

New method delivers Alzheimer’s drug to the brain

Date:
April 5, 2011
Source:
University of Oxford
Summary:
Scientists have developed a new method for delivering complex drugs directly to the brain, a necessary step for treating diseases like Alzheimer's, Parkinson's, Motor Neuron Disease and Muscular Dystrophy.

Oxford University scientists have developed a new method for delivering complex drugs directly to the brain, a necessary step for treating diseases like Alzheimer's, Parkinson's, Motor Neuron Disease and Muscular Dystrophy.

These diseases have largely resisted attempts to over the last 50 years develop new treatments, partly because of the difficulty of getting effective new drugs to the brain to slow or halt disease progression.

The team has successfully switched off a gene implicated in Alzheimer's disease in the brains of mice by exploiting exosomes -- tiny particles naturally released by cells. The exosomes, injected into the blood, are able to ferry a drug across the normally impermeable blood-brain barrier to the brain where it is needed.

Although this is a significant and promising result, there are a number of steps to be taken before this new form of drug delivery can be tested in humans in the clinic. The study, partly funded by the Muscular Dystrophy Campaign, is published in Nature Biotechnology.'

These are dramatic and exciting results. It's the first time new "biological" medicines have been delivered effectively across the blood-brain-barrier to the brain,' says Dr Matthew Wood of the Department of Physiology, Anatomy and Genetics at the University of Oxford, who led the work.

Exosomes are small capsules that are produced by most cells in the body in varying amounts. These natural nanoparticles are thought to be one of the ways cells communicate with each other and the body's immune system. When exosomes break off from the outer walls of cells, they can take various cellular signals and genetic material with them, transporting this material between different cells.

This led the Oxford University researchers to wonder whether exosomes could be adapted for delivering drugs to different cells and tissues of the body.

'This is the first time this natural system has been exploited for drug delivery,' says Dr Wood.

Novel drugs based on antibodies, peptides or more recently RNA molecules have been developed on many occasions to target specific parts of disease pathways. While these have shown good results in the lab, too often it has proved difficult to get the drugs to the right part of the body to see any effect in humans.

Currently, delivering any such type of therapy to the brain would have to involve neurosurgery. Nothing delivered intravenously would be able to cross from the blood into the brain.'

The major barrier for these drugs is delivery,' explains Dr Wood. 'This problem becomes even greater when you want to reach the brain. The blood-brain barrier -- which stops most things in the blood stream from crossing to our brains -- is much too great an obstacle.'

The Oxford University team set out to adapt naturally occurring exosomes to deliver a gene therapy. They used an RNA sequence -- RNA is a molecule related to DNA that also caries genetic information -- that switches off a gene that's implicated in Alzheimer's disease.

To be able to make the approach work, they would need to be able to load the exosomes with the RNA, the drug. But they would also need to be able to target the right tissues in the body.

First of all, they produced and purified exosomes from mouse cells. They then developed and patented new methods to both insert RNA molecules into the exosomes and add protein elements into the exosome coat that would target nerve cells.

The exosomes, injected intravenously into mice, crossed the blood-brain barrier and ended up in the brain. Once there, the RNA was able to switch off a gene implicated in the build up of malformed protein in Alzheimer's disease. This resulted in a 60% decrease in the brain of the problem enzyme encoded by the gene.

'We've shown that a natural system could be exploited to deliver drugs across the blood-brain barrier,' says Dr Wood. 'We believe we can use this same technology for Alzheimer's, motor neuron disease, Parkinson's and Huntington's. All we need is a different RNA each time.'

The next steps are to test the exosomes in a mouse model of Alzheimer's disease to see if it makes a difference to disease progression,' Dr Wood explains.

He also notes that other steps would be needed before exosomes could be tested in humans, including safety tests and scaling up the procedures.

'Many of these diseases have not been possible to treat in the last 50 years using standard drugs. New drugs have been developed based on complex biological molecules -- antibodies, peptides, and RNA -- but all require new ways of delivering the drugs,' he says.

'These natural nanoparticles would be administered intravenously, or perhaps even orally, and would still reach the brain.'


Story Source:

The above story is based on materials provided by University of Oxford. Note: Materials may be edited for content and length.


Journal Reference:

  1. Lydia Alvarez-Erviti, Yiqi Seow, HaiFang Yin, Corinne Betts, Samira Lakhal, Matthew J A Wood. Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nature Biotechnology, 2011; DOI: 10.1038/nbt.1807

Cite This Page:

University of Oxford. "New method delivers Alzheimer’s drug to the brain." ScienceDaily. ScienceDaily, 5 April 2011. <www.sciencedaily.com/releases/2011/04/110405124546.htm>.
University of Oxford. (2011, April 5). New method delivers Alzheimer’s drug to the brain. ScienceDaily. Retrieved July 25, 2014 from www.sciencedaily.com/releases/2011/04/110405124546.htm
University of Oxford. "New method delivers Alzheimer’s drug to the brain." ScienceDaily. www.sciencedaily.com/releases/2011/04/110405124546.htm (accessed July 25, 2014).

Share This




More Health & Medicine News

Friday, July 25, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Beatings and Addiction: Pakistan Drug 'clinic' Tortures Patients

Beatings and Addiction: Pakistan Drug 'clinic' Tortures Patients

AFP (July 24, 2014) A so-called drugs rehab 'clinic' is closed down in Pakistan after police find scores of ‘patients’ chained up alleging serial abuse. Duration 03:05 Video provided by AFP
Powered by NewsLook.com
Too Few Teens Receiving HPV Vaccination, CDC Says

Too Few Teens Receiving HPV Vaccination, CDC Says

Newsy (July 24, 2014) The Centers for Disease Control and Prevention is blaming doctors for the low number of children being vaccinated for HPV. Video provided by Newsy
Powered by NewsLook.com
New Painkiller Designed To Discourage Abuse: Will It Work?

New Painkiller Designed To Discourage Abuse: Will It Work?

Newsy (July 24, 2014) The FDA approved Targiniq ER on Wednesday, a painkiller designed to keep users from abusing it. Like any new medication, however, it has doubters. Video provided by Newsy
Powered by NewsLook.com
Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Newsy (July 24, 2014) Sheik Umar Khan has treated many of the people infected in the Ebola outbreak, and now he's become one of them. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

    Health News

      Environment News

        Technology News



          Save/Print:
          Share:

          Free Subscriptions


          Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

          Get Social & Mobile


          Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

          Have Feedback?


          Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
          Mobile: iPhone Android Web
          Follow: Facebook Twitter Google+
          Subscribe: RSS Feeds Email Newsletters
          Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins